Circular RNA hsa_circ_0032683 inhibits the progression of hepatocellular carcinoma by sponging microRNA-338-5p

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Circular RNAs (circRNAs) are crucial regulators of gene expression implicated in various cancers.
• The specific role of hsa_circ_0032683 in hepatocellular carcinoma (HCC) remains largely uninvestigated.
• Understanding circRNA functions offers potential for novel cancer biomarkers and therapies.

Purpose of the Study:

• To elucidate the function and mechanism of hsa_circ_0032683 in hepatocellular carcinoma (HCC).
• To determine the potential of hsa_circ_0032683 as a biomarker or therapeutic target for HCC.

Main Methods:

• Bioinformatic analysis of the Gene Expression Omnibus (GEO) database to assess hsa_circ_0032683 expression in HCC.
• In vitro and in vivo functional assays to evaluate the effects of hsa_circ_0032683 on HCC cell proliferation and apoptosis.
• Mechanistic studies involving microRNA (miRNA) and target gene interactions, specifically focusing on the competing endogenous RNA (ceRNA) network.

Main Results:

• hsa_circ_0032683 expression was significantly downregulated in HCC tissues compared to normal liver tissues.
• Overexpression of hsa_circ_0032683 inhibited HCC cell proliferation and induced apoptosis in vitro and in vivo.
• hsa_circ_0032683 functions as a ceRNA by sponging miR-338-5p to regulate the expression of its target gene, reticulon 4 (RTN4).

Conclusions:

• hsa_circ_0032683 plays an inhibitory role in HCC development by modulating the miR-338-5p/RTN4 axis via the ceRNA mechanism.
• hsa_circ_0032683 represents a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma.